drugset / Trial / NCT03109873
Metformin Hydrochloride in Affecting Cytokines and Exosomes in Patients With Head and Neck Cancer
Phase 0
Completed
9 enrolled
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
RandomizedParallel-groupDouble-blindSupportive care
Summary
This pilot clinical trial studies how well metformin hydrochloride works in affecting cytokines and exosomes in patients with head and neck cancer. Metformin hydrochloride may reduce the metabolic activity of cancer cells and of surrounding supportive tissues.
Timeline
- Start
- 2017-01-05
- Primary completion
- 2020-07-31
- Completion
- 2020-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Metformin | Small molecule | — | Oral |